105 related articles for article (PubMed ID: 10758248)
1. Improved systems for hydrophobic tagging of recombinant immunogens for efficient iscom incorporation.
Andersson C; Sandberg L; Wernérus H; Johansson M; Lövgren-Bengtsson K; Ståhl S
J Immunol Methods; 2000 Apr; 238(1-2):181-93. PubMed ID: 10758248
[TBL] [Abstract][Full Text] [Related]
2. General expression vectors for production of hydrophobically tagged immunogens for direct iscom incorporation.
Andersson C; Sandberg L; Murby M; Sjölander A; Lövgren-Bengtsson K; Ståhl S
J Immunol Methods; 1999 Jan; 222(1-2):171-82. PubMed ID: 10022383
[TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro lipidation of recombinant immunogens for direct iscom incorporation.
Andersson C; Wikman M; Lövgren-Bengtsson K; Lundén A; Ståhl S
J Immunol Methods; 2001 Sep; 255(1-2):135-48. PubMed ID: 11470294
[TBL] [Abstract][Full Text] [Related]
4. Applying biotin-streptavidin binding for iscom (immunostimulating complex) association of recombinant immunogens.
Wikman M; Friedman M; Pinitkiatisakul S; Hemphill A; Lövgren-Bengtsson K; Lundén A; Ståhl S
Biotechnol Appl Biochem; 2005 Apr; 41(Pt 2):163-74. PubMed ID: 15296488
[TBL] [Abstract][Full Text] [Related]
5. Characterization of immune responses to experimental polyvalent subunit vaccines assembled in iscoms.
Sjölander A; Ahlborg N; Ståhl S; Andersson R
Mol Immunol; 1998 Feb; 35(3):159-66. PubMed ID: 9694516
[TBL] [Abstract][Full Text] [Related]
6. High antibody responses in rabbits immunized with influenza virus ISCOMs containing a repeated sequence of the Plasmodium falciparum antigen Pf155/RESA.
Sjölander A; Lövgren K; Ståhl S; Aslund L; Hansson M; Nygren PA; Larsson M; Hagstedt M; Wåhlin B; Berzins K
Vaccine; 1991 Jun; 9(6):443-50. PubMed ID: 1887676
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity in rabbits and monkeys of influenza ISCOMs conjugated with repeated sequences of the Plasmodium falciparum antigen Pf155/RESA.
Sjölander A; Hansson M; Lövgren K; Wåhlin B; Berzins K; Perlmann P
Parasite Immunol; 1993 Jun; 15(6):355-9. PubMed ID: 8361778
[TBL] [Abstract][Full Text] [Related]
8. General strategies for efficient adjuvant incorporation of recombinant subunit immunogens.
Wikman M; Friedman M; Pinitkiatisakul S; Andersson C; Hemphill A; Lövgren-Bengtsson K; Lundén A; Ståhl S
Vaccine; 2005 Mar; 23(17-18):2331-5. PubMed ID: 15755622
[TBL] [Abstract][Full Text] [Related]
9. Genetic restriction and specificity of the immune response in mice to fusion proteins containing repeated sequences of the Plasmodium falciparum antigen Pf155/RESA.
Sjölander A; Andersson R; Hansson M; Berzins K; Perlmann P
Immunology; 1995 Mar; 84(3):360-6. PubMed ID: 7751017
[TBL] [Abstract][Full Text] [Related]
10. Peptide polymerisation facilitates incorporation into ISCOMs and increases antigen-specific IgG2a production.
Fernando GJ; Stenzel DJ; Tindle RW; Merza MS; Morein B; Frazer IH
Vaccine; 1995; 13(15):1460-7. PubMed ID: 8578827
[TBL] [Abstract][Full Text] [Related]
11. A dual expression system for the generation, analysis and purification of antibodies to a repeated sequence of the Plasmodium falciparum antigen Pf155/RESA.
Ståhl S; Sjölander A; Nygren PA; Berzins K; Perlmann P; Uhlén M
J Immunol Methods; 1989 Nov; 124(1):43-52. PubMed ID: 2681427
[TBL] [Abstract][Full Text] [Related]
12. Introduction of the haemagglutinin transmembrane region in the influenza virus matrix protein facilitates its incorporation into ISCOM and activation of specific CD8(+) cytotoxic T lymphocytes.
Voeten JT; Rimmelzwaan GF; Nieuwkoop NJ; Lövgren-Bengtsson K; Osterhaus AD
Vaccine; 2000 Oct; 19(4-5):514-22. PubMed ID: 11027816
[TBL] [Abstract][Full Text] [Related]
13. Effect of iscoms and their adjuvant moiety (matrix) on the initial proliferation and IL-2 responses: comparison of spleen cells from mice inoculated with iscoms and/or matrix.
Fossum C; Bergström M; Lövgren K; Watson DL; Morein B
Cell Immunol; 1990 Sep; 129(2):414-25. PubMed ID: 2383899
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant activity of iscoms; effect of ratio and co-incorporation of antigen and adjuvant.
Bengtsson KL; Sjölander A
Vaccine; 1996 Jun; 14(8):753-60. PubMed ID: 8817821
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulation by iscoms, immune stimulating complexes.
Morein B; Bengtsson KL
Methods; 1999 Sep; 19(1):94-102. PubMed ID: 10525444
[TBL] [Abstract][Full Text] [Related]
16. Current status and potential application of ISCOMs in veterinary medicine.
Morein B; Hu KF; Abusugra I
Adv Drug Deliv Rev; 2004 Jun; 56(10):1367-82. PubMed ID: 15191787
[TBL] [Abstract][Full Text] [Related]
17. Surface display compared to periplasmic expression of a malarial antigen in Salmonella typhimurium and its implications for immunogenicity.
Haddad D; Liljeqvist S; Kumar S; Hansson M; Ståhl S; Perlmann H; Perlmann P; Berzins K
FEMS Immunol Med Microbiol; 1995 Dec; 12(3-4):175-86. PubMed ID: 8745001
[TBL] [Abstract][Full Text] [Related]
18. HIV experimental vaccines based on the iscom technology using envelope and GAG gene products.
Akerblom L; Nara P; Dunlop N; Putney S; Morein B
Biotechnol Ther; 1993; 4(3-4):145-61. PubMed ID: 8292967
[TBL] [Abstract][Full Text] [Related]
19. Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses.
Morein B; Sundquist B; Höglund S; Dalsgaard K; Osterhaus A
Nature; 1984 Mar 29-Apr 4; 308(5958):457-60. PubMed ID: 6709052
[TBL] [Abstract][Full Text] [Related]
20. The immunomodulating properties of human respiratory syncytial virus and immunostimulating complexes containing Quillaja saponin components QH-A, QH-C and ISCOPREP703.
Hu KF; Regner M; Siegrist CA; Lambert P; Chen M; Bengtsson KL; Morein B
FEMS Immunol Med Microbiol; 2005 Feb; 43(2):269-76. PubMed ID: 15681158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
